Bioimpedance is the collective term that describes safe, non-invasive methods to measure the electrical responses to the introduction of a low-level, alternating current into a living organism, and the biophysical models to estimate body composition from bioelectrical measurements. Although bioimpedance techniques have been used for more than 100 years to monitor assorted biological components, the desire to translate bioelectrical measurements into physiological variables advanced the creation of empirical prediction models that produced inconsistent results. SUBJECTS/METHODS: This paper succinctly reviews the origin, and critically evaluates the conceptual models and the implementation of bioimpedance in clinical research, including indirect assessment of assorted physiological functions and body composition (fluid volumes and fat-free mass), classification of hydration, regional fluid accumulation, prognosis in disease and wound healing. RESULTS: Despite widespread and mounting interest in the use of bioimpedance to characterise body structure and function, most experimental findings reveal the limitations of existing physical models and reliance on multiple regression models for use in assessments of an individual. CONCLUSIONS: Contemporary applications of bioimpedance emphasise the value of bioimpedance variables per se in some novel biomedical applications with the objective of identifying opportunities for future outcome-based research.
INTRODUCTION
The history of the use of electrical current to explore tissues and reveal information about its composition and function recognises various contributions that are the basis for contemporary bioimpedance analysis. 1 The chronology of bioimpedance research highlights an interesting sequence of events that range from the development of biophysical models to address applications in the estimation of pulsatile blood flow [2] [3] [4] to assessment of body composition. [5] [6] [7] [8] Remarkably, novel applications of bioimpedance come back to clinical applications that challenge existing bioimpedance methods and models as too imprecise to enable diagnosis and assessment of effects of intervention for an individual. This review concisely describes diverse bioimpedance applications in the assessment of biological function and body structure, summarises the strengths and the limitations of conventional models and emphasises new and emerging bioimpedance models that advance the bioimpedance method in outcome-based research.
BIOIMPEDANCE MODELS Impedance
Ranging from in vitro studies of tissues and cells in suspension to dynamic changes in the distribution of body fluids in response to illness and interventions, the physical bases for the conversion of in vivo electrical measurements into physiological parameters originate in a common origin and evolve into different experimental approaches. The commonality is the equivalent circuit ( Figure 1 ) proposed by Fricke 9 and expanded by Cole 10 and represents the basis for the use of bioimpedance in studies of body structure and function. This model describes extracellular and intracellular ionic fluids as parallel resistors and the cell membrane as a capacitor.
Non-invasive bioelectrical assessments begin with an understanding of impedance. Ohm's Law 1 states that the flow of an electrical current (I) passing through two points of a conductor is equal to the voltage drop (V) divided by the electrical resistance (R) between these points:
It is based on the introduction of direct current into a simple conductor with cylindrical shape such as a wire. If the current remains constant, the change in voltage across the circuit is equal to the change in the resistance to the current flow. Generalisation of Ohm's Law to alternating current yields the concept of electrical impedance (Z) or simply impedance that is elaborated as Z ¼ V/I. The electrical impedance of an electrical circuit is considered to include two parameters, R and reactance (Xc) (Figure 2 ), and is described as follows:
The concept of electrical impedance is important because only alternating current is introduced into humans, and it enables the use of three variables (resistance, reactance and phase angle) as indices of biological variables.
11
Living organisms consist of conductive and non-conductive components with fluid volumes, tissue properties and cell membranes as the primary electrically recognised constituents. When an organism becomes a component of a safe and highly controlled electrical circuit, the measured change (decrease) in voltage following the administration of a safe, radiofrequency, alternating current yields bioelectrical measurements that designate structural and functional biological variables. 12 Resistance is the opposition to the flow of an alternating current through intracellular and extracellular ionic solutions. Conductance, which is the inverse of resistance, is an alternative bioelectrical concept. Reactance represents the delay in the conduction or passage of the administered current by cell membranes and tissue interfaces. Capacitance, due to membrane structure and function, is a function of reactance and causes the current to lag behind the voltage, creating a phase shift or phase angle 13 that is quantified as the angular transformation of the ratio of reactance to resistance (arc tangent (Xc/R) 1801/p, and expressed in degrees).
Bioelectrical impedance spectroscopy (BIS)
Impedance spectroscopy is another method to assess biological parameters.
14 It uses nonlinear mathematical modelling to fit measured impedance and phase-angle data, from which reactance is calculated, derived from a wide range of frequencies, generally from 4 to 1000 kHz. 15 Biophysical modelling of the spectral (R and Xc) data with nonlinear, leastsquares curve fitting yields an interrupted semicircle or impedance locus ( Figure 3 ) that generates Cole model variables, 15 principally R 0 (also termed R e or the resistance associated with extracellular fluid), R N (resistance associated with the sum of intracellular plus extracellular fluids), critical frequency indicated at the largest reactance value and membrane capacitance (C m ). These resistance parameters are used to calculate intracellular resistance (Ri) as follows:
Mixture theory 16 incorporates these resistance values to predict fluid volumes as described elsewhere. 15, 17 Briefly, mixture theory is a theoretical model to describe the apparent conductivity within a heterogeneous entity based on the distribution of conductive (water and ionic material) and non-conductive (anhydrous components such as bone, fat and cell membranes) materials in the body. Extracellular water (ECW) and intracellular water are predicted separately; total body water (TBW) is the sum of these values. The calculation of extracellular and intracellular fluid volumes depends on equations that include the estimated resistance parameters listed above, scalar factors (computed from measurements of body weight (kg) and height (m), and an assumed body density value) and empirically derived, genderspecific resistivity constants. Extracellular fluid (V ECF ) is calculated as follows:
and k ECF ¼ 10
, where K B is a body geometry factor that relates relative volume of the legs, arms and trunk, r ECF is the resistivity of the extracellular fluid and D b is total body density. These calculations are performed with the software provided by
Phase angle
Resistance, ohm Reactance, ohm Figure 1 . Equivalent electrical circuit to describe the bioelectrical components of a living cell. When a radiofrequency, alternating current, is applied to the body, it is attenuated by water and electrolytes in the extracellular (R e ) and intracellular (R i ) fluids and characterised as resistance (R). The current is stored and released at cell membranes; it is measured as reactance or cellular capacitance (C m ). Both resistance and reactance are frequency dependent.
the manufacturers of the BIS instruments, and are subject to change.
18 VOLUME CONDUCTOR MODEL FOR VOLUME PREDICTION The physical model that relates impedance or resistance to volume is well known. In a uniform conductor with constant geometry and composition, impedance (Z, O) is related directly to the product of specific resistivity (r, Ocm 2 ) and length (L, cm) of the conductor, and indirectly to conductor cross-sectional area (A, cm The use of an alternating current and cylindrical electrical conductor allows
Application of this model in biology rests on certain assumptions. The bioelectrical conductor is assumed to have a relatively homogeneous composition (for example, constant composition and hydration) and constant geometry including cross-sectional area and shape. Divergence from any of these assumptions, however, affects the validity of this model in health and disease.
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IMPEDANCE PLETHYSMOGRAPHY AND PULSATILE BLOOD FLOW Nyboer et al. 19 pioneered the application of bioimpedance as an alternative to invasive procedures to assess peripheral vascular function. He coined the term 'impedance plethysmography' to detect changes in the blood flow in extremities. 20 The impedance system used a 150-200-kHz AC current with four (tetrapolar) circumferential, aluminium foil, band electrodes contacting the skin with electrolyte-containing paste and positioned on the arm or leg. The proportional impedance response was related to volumetric changes:
where DV is the blood flow (ml), r is the resistivity of the blood (Ocm), Z 0 is the baseline impedance (O) before systole and DZ is the change in impedance (O) from baseline to the peak value. This initial approach included a simultaneous determination of impedance and an electrocardiogram to coordinate the mechanical aspects of systole with estimates of regional blood flow. This technique records variations in the electrical volume (size) of a limb due to vascular volume changes. 2, 21, 22 The basic principle is that the impedance of the anatomical site is inversely related to blood flow or volume. 19 Thoracic bioimpedance Building on the pioneering work of Nyboer, 19 Kubicek et al.
22
estimated blood flow in the aorta by measuring impedance changes in the thorax, and described this method as 'thoracic electrical bioimpedance'. Kubicek et al.
23
used Nyboer's hypothesis 19 that blood had a much lower resistivity relative to the tissues and organs in the thorax, and thus it would be a better conductor of applied current; therefore, changes in thoracic impedance would be related to blood flow during systole. This approach estimated stroke volume (SV) similar to the pulse contour method developed by Nyboer et al. 19 but overcame the signal artefact associated with respiration by measuring thoracic impedance at end expiration and using the first derivative of the change in impedance over time along with circumferential band electrodes around the neck and thorax. Calculation of SV required multiplication of the area under the curve of the pulse pressure wave form, characterised as dZ/dt max, by the left ventricular ejection time (LVET):
with r as the assumed resistivity of blood at 100 kHz (150 Ocm) and (dZ/dt) max as the maximum of the first derivative of the Z wave form. Subsequent modifications of the Kubicek thoracic impedance model 23 have been implemented to account for the interindividual variations of the electrically participating tissue, including the geometry of the thorax as a cone that constitutes 17% of thoracic volume, and to scale for derivations from ideal body weight. 24 Validation studies of the thoracic bioimpedance method with the standard methods of assessment of cardiac output found significant correlation coefficients ranging from 0.61 to 0.93 with a weighted average of 0.81 but with wide limits of agreement of B10% or 1-2 l/min. 22, 25 The advantage of impedance plethysmography and thoracic bioimpedance is the noninvasive, continuous monitoring of individuals. Limitations include artefacts associated with morbid obesity, short neck, extensive hair on the thorax, diaphoresis and inability to localise landmarks for electrode placement. 26 Clinical conditions, such as pneumonia, pleural effusions, haemothorax and pneumothorax, vascular anomalies, third space enlargement, body motion and environmental electrical interference may impair the accuracy of these applications. 26 Bioreactance Bioreactance is the newest techniques for non-invasive monitoring of cardiac output. 27 It is based on the analysis of relative phase shifts to a low-level alternating current that occur when this current traverses the thoracic cavity, and contrasts with bioimpedance systems that rely on measured changes in amplitude of impedance in response to an administered oscillating current. In addition to changes in resistance due to blood flow, changes in intrathoracic blood volume also produce changes in the electrical capacitative and inductive properties due to blood cells that result in phase shifts of the received signal relative to the applied signal. The phase shifts are less susceptible to detection problems because they do not degrade with distance between detecting electrodes, and thus SV determinations are not dependent on the distance between electrodes.
This system uses a 75-kHz AC and four dual-sensor, spot electrodes or contacts placed on the skin. Within each contact, one electrode introduces the signal (current), whereas the other detects the voltage drop. Two contacts are positioned on the right side and two others are placed on the left side of the body; this arrangement results in a pair of contacts so that the currents are passed between the outside electrodes and the voltage drops are recorded by the inside pair. Bioreactance data are determined separately from each side of the body, with the final signal being the average of the two signals.
SV is expressed as a function of VET, the maximum phase shift over time (dø/dt max ) and the body proportionality constant (C):
Validation studies report accuracy similar to, if not better than, thoracic bioimpedance. 25 Correlations with traditional measurements of cardiac output are high (r ¼ 0.8-0.9), with bias estimates ranging from 4 to 9% of reference values under a wide range of circulatory situations. 28 Advantages of the bioreactance method compared with thoracic bioimpedance are an increased signal-to-noise ratio, the independence of phase shifts from distance between detecting electrodes and thus convenience of lead placements on the patient. In addition, anatomical conditions (obesity and short neck) and diaphoresis do not affect signal strength. 26 A recurrent problem with the use of thoracic electrical impedance and bioreactance to estimate cardiac output is the lack of attention given to inter-individual differences in haematocrit. These techniques use a constant value for blood resistivity despite the awareness that packed cell concentration (7.5%), and the orientation of blood cells (4.5%) in the electrical field independently affect whole-blood resistivity values. 29 Failure to account for these factors contributes to the reported wide limits of agreement in comparisons with reference methods.
BODY COMPOSITION
Bioimpedance technology is an attractive tool for routine assessment of human body composition, because it is safe, inexpensive, portable, rapid, convenient for use and highly reproducible. 5, 6, 30 The technique usually uses four contact electrodes placed ipsilaterally on a hand and a foot. Bioimpedance analysis is an indirect method to assess body composition, and uses electrical characteristics to index compositional variables. It relies on correlation and multiple regression analysis, and the assumptions of constant body geometry and composition of the fat-free body, to predict body composition. Implementation of these assumptions prompted concerns regarding the accuracy of bioimpedance predictions for an individual. 5, 6, 31, 32 The following examples highlight the problems inherent with these approaches in assessment of fluid volumes and fat-free mass (FFM) with bioimpedance methods.
Estimation of fluid volumes in health and disease
Single-frequency bioimpedance. Equations to estimate TBW from single-frequency bioimpedance derive from the volume conductor model (Equation 8 ) and multiple regression analysis. Hoffer et al. 33 found a significant correlation between Ht 2 /Z and TBW in healthy and ill adults (r ¼ 0.92 and 0.93, respectively) and suggested the further development of this method for clinical use. Lukaski et al. 30 and Segal et al. 34 extended this finding with a 50-kHz current and Ht 2 /R as the independent variable. Investigators subsequently used multiple regression analysis, including Ht 2 /R at 50 kHz and other independent variables (body weight, age and gender), to decrease the predictive error (s.e. of the estimate) of estimating TBW in groups. 35, 36 Although this strategy improved the precision of prediction equations (for example, lowered s.e. of the estimate values substantially), crossvalidation studies using these models to predict TBW demonstrated either inaccuracy (for example, significant differences between measured and predicted values) or wide variability in individual predictions in other groups of healthy people or groups characterised as obese, weight-reduced or perturbations associated with chronic disease. Similar negative findings were reported for regression models to predict ECW in healthy and ill children and adults. [5] [6] [7] 37 Bioelectrical impedance spectroscopy. Thomasset 38, 39 initiated the use of multiple-frequency bioimpedance to estimate fluid volumes when he used low (usually 5 kHz) and high (typically 4100 kHz) frequency currents and multiple regression equations to predict TBW and ECW in humans. This fundamental work was advanced with the development and application of BIS. 8 Comparisons of spectroscopic predictions of fluid volumes with reference values derived from isotope dilution methods revealed inconsistent findings among various groups of individuals. Generally, BIS estimates of TBW and ECW were significantly correlated with measured values. [5] [6] [7] [8] However, significant differences between predicted and measured values were commonly found in healthy adults and groups with various pathologies. [5] [6] [7] [8] 40 Among adults undergoing changes in TBW and ECW, BIS yielded reasonably consistent predictions of TBW and ECW compared with isotope dilution measurements; however, bias in TBW predictions increased with increasing TBW levels. 41, 42 Predictions of change in intracellular water with BIS after anabolic therapy were significantly different than values determined by using isotope dilution measurements. 42 Impedance spectroscopy significantly overpredicted TBW and ECW during weight loss in severe obesity, and the differences between predicted and measured values increased with fat loss. 7, 43 In contrast, Mager et al. 44 reported significant underestimation of TBW and ECW with BIS in patients after gastric bypass surgery and weight loss. Wide limits of agreement have been reported consistently for BIS in nearly all validation studies, [5] [6] [7] [8] 44, 45 and raise concerns about the value of these predictions in clinical applications. 46 Assessment of FFM Single-frequency bioimpedance. The assumption of a constant hydration of the fat-free body is the basis for the use of 50 kHz bioimpedance to estimate FFM. Although many impedancebased, multiple regression models are available to predict FFM, cross-validation in independent samples is generally lacking except among healthy adults. 6, 7 Predictions of FFM with these single-frequency bioimpedance models, however, tend to overestimate FFM in subjects with an expanded ECW, such as renal insufficiency, congestive heart failure, severe obesity and hepatic disease. 5, 7 Moreover, assessments of change in FFM with single-frequency bioimpedance particularly after weight loss or gain, either intentionally or owing to illness, differed significantly from reference measurements. 7, 47 These findings suggest that alterations in the assumptions of constancy of composition of the fat-free body or body geometry contributed to the errors in prediction of body composition change.
Bioimpedance spectroscopy. There is a paucity of data describing the validity of BIS to predict change in FFM. Vine et al. 48 reported significant correlations for BIS-predicted and dual X-ray absorptiometry FFM in end-stage renal patients on dialysis, undialysed renal patients and healthy control subjects. Although no significant differences were found between methods, very wide limits of agreement (B10 kg) for BIS predictions were observed for all groups, which suggests the limited clinical use of BIS for patients with end-stage renal disease. Ellegård et al. 49 found that BIS significantly underestimated FFM in cancer patients who had undergone large weight losses. The bias of the BIS prediction was significantly correlated with percent weight loss and biochemical indices of malnutrition and weight loss. Similarly, BIS significantly overestimated FFM compared with dual X-ray absorptiometry in overweight and obese men. 50 
HYDRATION STATUS
Non-invasive assessment of hydration remains a critical need in clinical medicine, particularly in acute settings. An increase in body fluid volume of 3-4 l is detectable as pitting oedema. A subclinical increase in fluid volume without oedema and mild to moderate dehydration, however, are difficult to diagnose clinically. 51 Traditional methods such as isotope dilution are not amenable for point-of-care use, and standard clinical evaluation methods (for example, physical examination, laboratory studies and medical history) are inaccurate and fail to distinguish immediately normal hydration, dehydration and overhydration in patients. 52 Although single-frequency bioimpedance and BIS have been used to assess fluid volumes in health and disease, they provide estimates of fluid volumes that are too variable for clinical use. 53 Bioelectrical impedance vector analysis (BIVA) This method uses whole-body resistance and reactance values derived from a 50-kHz signal, normalised for standing height and plotted on the RXc graph, and yields a vector that has length and direction. 54 The length of the impedance vector is inversely related to TBW, 55 and the combination of the vector length and its direction, defined as the phase angle, is an indicator of tissue hydration status. 55, 56 Impedance vector analysis enables classification (under-, normal and overhydration) and ranking of hydration (more or less than before intervention), as well as soft-tissue mass, for an individual by examining the position of the vector relative to a healthy reference population. The advantage of BIVA compared with single-and multiple-frequency bioimpedance predictions is the elimination of multiple sources of error, including impedance measurement and reproducibility (1-2%), regression error of prediction equation (410%), 31 technical error in the reference method (B5%), limitations of the bioelectrical volume model (that is, anisotropy of tissues and geometry other than a cylinder) and biological variability (that is, inter-individual body composition differences) that propagate. 53 In contrast, the BIVA method only depends on the reproducibility and accuracy of BIA measurements and intra-individual variability in body composition, which have low magnitude of error. Therefore, for an individual, classification and ranking of hydration is more precise and accurate than is quantification of fluid volume, because BIVA is independent of regression models that are generated in limited and specific samples and, thus, are not robust in the assessment of hydration outside of the group in which they were developed and are adversely affected by illness.
The inter-subject variability of the impedance vector is represented by the bivariate normal distribution with elliptical probability areas (50, 75 and 95%) in the tolerance ellipses for individual vectors (Figure 4) . Thus, BIVA uses patterns of impedance vector distribution without the need for prediction equations, body weight or reliance on stable composition of the FFM. Changes in tissue hydration status of o500 ml are detected and ranked in real time. 53 Vector position on the RXc graph is interpreted relative to the two directions on the RXc plane. Vector displacements parallel to the major axis of tolerance ellipse indicate progressive changes in tissue hydration; dehydration is associated with long vectors outside of the upper region of 50% tolerance ellipse, and fluid overload with apparent oedema is characterised with short vectors out of the lower pole of the 50% ellipse. Peripheral vectors in the left side of the major axis, or in the right side of the major axis, of tolerance ellipse indicate more or less cell mass, respectively. 54 Accumulating evidence emphasises the value of BIVA in physiological and clinical conditions. Overhydration was identified in late pregnancy and postpartum, as well as in weight-reduced obese adults with BIVA, and validated with isotope dilution methods. 53, 55 The use of BIVA improved the prescription of ultrafiltration in dialysis by monitoring the backward-forward displacement of vectors in relation to the wet-dry cycle of haemodialysis, and enhanced decision-making in dialysis by facilitating the interpretation of alterations in blood pressure relative to hydration status and thus adjusting ultrafiltration. Recent evidence supports the use of BIVA in the assessment of volume overload in patients with acute heart failure 57 and discriminating pulmonary compared with cardiac dyspnoea, 58 as well as its importance in guiding individualised volume reduction therapy because of its high sensitivity and specificity. 59 Importantly, the combination of BIVA assessment of hydration status in conjunction with measurements of brain natriuretic peptide significantly decreased readmission rates of patients discharged with a diagnosis of heart failure. 58, 60 REGIONAL FLUID ACCUMULATION Accumulation of fluid in the limbs may be a consequence of pathology or surgical intervention. Characterisation of peripheral oedema is problematic unless it is severe, such as pitting oedema. Post-surgical oedema and lymphoedema associated with breast cancer are two conditions in which varying degrees of fluid accumulation occur. Two specific bioimpedance approaches have been described to enable objective assessment of peripheral oedema.
Segmental BIVA This method uses the basic approach of whole-body impedance vector analysis with some modification for regional measurements. Patients with peripheral arteriopathy underwent determinations of whole-body and leg bioimpedance with a 50-kHz phase-sensitive device before and after surgery. 61 Bioimpedance was determined individually on the unaffected and affected legs with source electrodes placed on the foot and the hip at the greater trochanter and detector electrodes positioned on the foot and 7 cm proximal to the current-introducing electrode. Distance between detector electrodes (L) was used for the determination of the impedance vector for each leg. Before surgery, the confidence ellipses of the vectors for both legs overlapped, which indicated a comparable mean vector and hydration. After surgery, however, the operated leg that developed oedema had a significantly 
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More Fluids Phase Angle Figure 4 . Model of BIVA to rank hydration and soft-tissue mass. R is the resistance, Xc is the reactance and H is the height. Adapted from Piccoli et al. 54 affected arm compared with the unaffected arm of women with lymphoedema, and these values were also significantly less than those in the matched arms of control women. 62 This novel approach used current-injecting electrodes placed on the conventional hand and foot locations, with detector electrodes positioned on the wrist and at the end of a 40-cm length up the arm to maximise the potential to fluid-related effects on impedance measurements. 63 Because of the wide biological variation between individuals in arm impedance values, impedance per se does not differentiate well between the affected and the unaffected limb. Thus, the impedance of the affected limb is normalised to that of the contralateral or unaffected limb and expressed as a ratio; individual patient values 43 s.d. (derived in a healthy control group of women) serve as the detection limit for early-stage lymphoedema and for monitoring effects of therapy. 64 Lymphoedema may also present bilaterally and poses a problem for diagnosis and surveillance. Ward et al. 65 proposed that the ratio of the calculated intracellular and extracellular resistance (R I /R 0 ) of each limb (arm or leg) would provide insight into the diagnosis of peripheral lymphoedema. Data were collected from lymphoedema patients and age-matched healthy control adults. The R I /R 0 ratios varied with age, gender and limb dominance. However, comparisons of the ratios for an affected limb, normalised to the ratio of unaffected limbs and compared with control data expressed as bivariate distributions, identified nearly 90% of individuals with lymphoedema.
M o r e S o f t T is s u e s L e s s S o f t T is s u e s
Some limitations of BIS were identified in comparison with perometry, a reference method to assess limb volume. Although BIS ratios and perometry volume values were highly correlated (total arm: r ¼ 0.89; segments: r ¼ 0.46-0.78), the average BIS interlimb ratios for the total arm and each segment were greater than comparable perometry measures in women with lymphoedema. 66 Limits of agreement showed that the mean difference differed by segment ranging from 8.5% for the uppermost segment of the arm to 16.6% for the forearm adjacent to the elbow. The BIS measurements overestimated volume, and increased with the severity of lymphoedema.
WOUND HEALING
Single-frequency, phase-sensitive bioimpedance measurements offer a novel opportunity to non-invasively monitor wound healing. Studies of cells in culture and surgical procedures in rodents revealed that increases in resistance are directly related to epithelial cell growth and healing, whereas decreases in resistance indicate acute injury. 67, 68 Serial measurements with four, surfacecontact electrodes placed adjacent to the wound enabled longitudinal monitoring of the direction of the change in resistance values, with a positive slope indicative of epithelialisation and healing and a negative slope suggestive of complications such as infection or graft failure. 69 Impedance measurements discriminated the risk for pressure ulcers among bedridden individuals. 70 Phase-sensitive measurements were taken at the trochanter and coccyx of adults at different levels of risk for pressure ulcers. Patients at high risk for pressure ulcers, compared with controls, had significantly reduced reactance, resistance and phase-angle values that signal fluid accumulation in the extracellular space and reduced cellular vitality.
Bioimpedance non-invasively illustrates cell architecture and processes during wound healing. Resistance is inversely related to extracellular fluid volume and proportional to fibrin clot formation that leads to epithelialisation. Increases in reactance, which is related to cell mass, indicate epidermal proliferation and granulation of the wound. Thus, bioimpedance provides insights into healing and may advance patient care. PROGNOSIS Prognosis, characterised as the usual course of a disease, is an uncertain process that integrates clinical data derived from biomedical tests and physician experience to predict possible future outcomes of a disease or a treatment for an individual. Prognostic accuracy is limited because conventional statistically based methods are too imprecise for individual patient use. Bioimpedance affords an emerging opportunity to improve prognosis because of its ability to non-invasively assess cell membrane structure and function by means of phase angle. 7, 11, 13 Whole-body bioimpedance Conventional whole-body bioimpedance measurements at 50 kHz using hand-to-foot electrode placements revealed that phase angle is an excellent predictor of morbidity and mortality in many types of chronic disease. 71 Age, gender, body mass index, nutritional status and physical activity affect phase-angle values. [72] [73] [74] Thus, larger phase-angle values (51-91) may be proportionally considered an index of vitality, with lower ranges indicative of frailty. 75 Ranges of phase-angle values, stratified by gender and age, highlight increased risk of poor prognosis in patients. For example, values o51 predict decreased function (for example, muscle strength) and quality of life 76 and increased mortality among patients with different types of cancers. 75 Stobäus et al. 71 reported retrospectively that inflammation was an independent predictor of low phase angle but only in midrange concentrations of the C-reactive protein. This finding is noteworthy and suggests the need for prospective research to further clarify the prognostic value of phase angle, and specifically to ascertain whether the direction (increase or decrease) and rate of change (slope) of phase-angle values from control, determined at diagnosis or early in the disease process, is a valid indicator of future morbidity or mortality. Furthermore, the change in phase angle in response to therapeutic intervention should be examined to confirm initial findings that a 11 increase in phase angle was associated with a 25% increase in survival among patients with advanced cancer. 75 Localised bioimpedance and neuromuscular disease Recognition that conduction of an applied radiofrequency current is affected by arrangement and integrity of cell membranes led to the use of bioimpedance to characterise electrical anomalies in neuromuscular diseases. Currents flowing perpendicularly to muscle fibres encounter more cell membranes than do currents flowing along them. 77 This observation is the basis for the change in phase angle measured at different sites along a limb and is described as a phase curve, the average of which is termed the average phase. The measured resistivity also is influenced by muscle fibre arrangement and cell membrane integrity, which leads to the concept of effective resistivity. Phase and resistivity are determined by the arrangement of muscle fibres, and this effect is termed anisotropy or directional dependence to current flow. The use of phase angle minimises the effects of muscle size and shape on impedance per se.
Electrode positions are modified to include the limb to be examined. Current-introducing electrodes are placed distally on each limb (for example, foot or hand) and voltage-sensing electrodes are positioned at fixed distances transversely along the long axis of the limb. A 50-kHz alternating current is introduced and a phase-sensitive device is used to take resistance, reactance and phase measurements; 77 this method is termed linear electrical impedance myography. Observational studies found that the average phase was significantly decreased, whereas effective resistivity was significantly increased in the thighs of patients with neuromuscular disease compared with healthy controls. Reductions in phase correlated with disease progression, whereas normalisation of phase correlated with disease remission. Importantly, quadriceps strength was significantly correlated with the inverse of average phase (r ¼ 0.67). Follow-up studies demonstrated that average phase measured across the tibialis anterior decreased (6.61) 28% during immobilisation, compared with the non-injured leg, and increased (9.71) 28% following rehabilitation, whereas the non-casted leg did not change appreciably (9.64-10.211 or 6.7%). 78 This method has been used successfully to characterise deterioration and progress in response to therapy in other neuromuscular diseases. 79 Multiple-frequency bioimpedance and multiple orientation assessment have been initiated. 79, 80 These findings demonstrate the promising value of regional bioimpedance in diseases affecting skeletal muscle.
SUMMARY AND CONCLUSIONS
The practical advantages of the bioimpedance method have enabled the widespread use of this method in many research applications. The preponderance of experimental evidence demonstrated that the use of the single-and multiple-frequency bioimpedance analysis using the simple conductor-volume model and multiple regression analysis resulted in large errors of prediction of TBW, ECW and FFM in people. Moreover, these errors persisted and grew in applications with groups characterised as fluid overloaded, dehydrated or obese. Similar problems have emerged in the use of BIS, particularly in groups of volunteers who had undergone changes in body weight, composition or fluid volume. Collectively, these findings indicate that violations in the assumptions of these methods occurred in these applications. Reliance on the constancy of the composition of the fat-free body (for example, hydration), consistent body geometry and the use of constant values for intracellular and extracellular resistivity contributed to the errors in the estimation of body composition.
The combination of raw bioimpedance values and avoidance of mathematical prediction equations appears to have overcome these limitations. The use of BIVA to classify and rank hydration in various clinical conditions, the application of the ratio of low to high impedance in regional assessments of lymphoedema, longitudinal measurements of single-frequency bioimpedance to monitor wound healing, determinations of phase angle to aid in prognosis and regional bioimpedance measurements to evaluate skeletal muscle in neuromuscular disease are novel and promising applications.
The fundamental advancement in recent bioimpedance research is the use of raw impedance measurements. At present, BIVA, phase angle and regional BIS evaluate bioimpedance data relative to statistical-based reference norms for identification of physiological perturbation and evaluation of effects of intervention. Additional research is encouraged to extend this approach to regional bioimpedance in neuromuscular disease. The high precision of these new approaches allows for their use in individuals and should facilitate their transition from observational to outcome-based research.
